Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147769 · ClinicalTrials.gov registry record
Cerebral Oxygenation and Autoregulation in Preterm Infants
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 111
- Enrollment target
NCT02147769: Completed study, sponsored by Stanford University.
NCT02147769 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02147769 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated. This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.
Interventions
- DEVICE NIRS monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147769
The ClinicalTrials.gov registry entry for NCT02147769 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRS monitoring is the first listed.
NCT02147769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147769 about?
NCT02147769 is a clinical study titled "Cerebral Oxygenation and Autoregulation in Preterm Infants". Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and o...
What is the current status of trial NCT02147769?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2014-05. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02147769?
The interventions under investigation include: NIRS monitoring (DEVICE).
Who is sponsoring clinical trial NCT02147769?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.